secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALVELLA THERAPEUTICS, INC. (PVLA)
CIK:        0001583648
Form:       8-K
Filed at:   2025-06-11T23:59:59+00:00
Accession:  0001104659-25-058532
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Palvella shareholders elect Heron, Wessel as Class II directors; ratify EY
--------------------------------------------------------------------------

- Elaine J. Heron elected with 6,647,082 votes for, 1,255 withheld; Tadd S. Wessel with 6,487,034 for, 161,303 withheld.
- Ratification of Ernst & Young as independent auditor for 2025: 7,299,907 for, 8,352 against, 7,334 abstain.
- Advisory approval of 2024 named executive officer compensation: 6,550,393 for, 61,078 against, 36,866 abstain.
- Broker non-votes on proposals 1 and 3 were 667,256.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583648/000110465925058532/0001104659-25-058532-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583648/000110465925058532/tm2517565d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-058532

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer